Nasdaq bsgm.

Contact Data Andrew Ballou BioSig Technologies, Inc. Vice President, Investor Relations 54 Wilton Road, 2nd floor Westport, CT 06880 [email protected] 203-409-5444, x119BioSig’s Technologies, Inc (Nasdaq: BSGM) subsidiary, ViralClear Pharmaceuticals, Inc. (ViralClear), is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19.The average one-year price target for Biosig Technologies (NASDAQ:BSGM) has been revised to 5.74 / share. This is an increase of 38.89% from the prior estimate of 4.13 dated October 31, 2023. The ...BioSig Technologies, Inc. Common Stock (BSGM) Advanced Charting - Nasdaq offers advanced charting & market activity data for US and global markets. The latest price target for . BioSig Technologies (NASDAQ: BSGM) was reported by Ascendiant Capital on Monday, February 13, 2023.The analyst firm set a price target for 5.00 expecting BSGM to rise ...

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal ...BSGM is the ticker symbol for BioSig Technologies, Inc., a medical technology company that provides intracardiac signal visualization. The …

Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented ...Westport, CT, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering ...

Shareholder contact: Andrew Ballou BioSig Technologies, Inc. Vice President, Investor Relations 54 Wilton Road, 2nd floor Westport, CT 06880 [email protected] 203-409-5444, x133 Media contact ...BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering unprecedented accuracy and precision to ...Nov 6, 2023 · In the last trading session, 1.07 million shares of the Biosig Technologies Inc (NASDAQ:BSGM) were traded, and its beta was 1.31. Most recently the company’s share price was $0.51, and it changed around $0.05 or 10.04% from the last close, which brings the market valuation of the company to $37.93M. BSGM currently trades at a discount to its ... Westport, CT, May 07, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) today appointed Mr. Michael Schmertzler to the Board of Directors of its ...

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) an advanced digital signal processing technology company delivering unprecedented accuracy and precision to ...

Westport, CT, July 13, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company") and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced the ...

1 feb 2021 ... (NASDAQ: BSGM), Alphabet Inc. (NASDAQ: GOOG), Teladoc Health, Inc. (NASDAQ: TDOC), Splunk® Inc. (NASDAQ: SPLK), NVIDIA Corporation (NASDAQ: NVDA) ...Westport, CT, Dec. 06, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing an innovative signal processing ...Westport, CT, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Westport, CT, Nov. 9, 2023 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to ...Shutthiphong Chandaeng. BioSig Technologies ( NASDAQ: BSGM) traded higher on Thursday after the medical device company announced that its subsidiary, BioSig AI Sciences, Inc., was selected to join ...Westport, CT, May 03, 2021 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal ...

Andrew Ballou BioSig Technologies, Inc. Vice President, Investor Relations 55 Greens Farms Road, 1st Floor Westport, CT 06880 [email protected] 203-409-5444, x133.Westport, CT, April 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) today announced that on April 16, 2020 its subsidiary ViralClear ...Westport, CT, Oct. 26, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”) and its majority owned subsidiary, ViralClear Pharmaceuticals, Inc ...Contact Data Natasha Drapeau BioSig Technologies, Inc. Executive Vice President 54 Wilton Road, 2nd floor Westport, CT 06880 [email protected] 203-409-5444, x119BSGM BSGM AFTER HOURS QUOTE BSGM LATEST AFTER HOURS TRADES. ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, ...

The public float for BSGM is 64.09M, and currently, shorts hold a 3.17% of that float. The average trading volume for BSGM on November 16, 2023 was 284.74K shares. BSGM) stock’s latest price update. Biosig Technologies Inc (NASDAQ: BSGM) has experienced a decline in its stock price by -6.10 compared to its previous closing price of 0.39.BSGM Latest Real Time Trades. Select time range to see more trades: Last 100 Trades. NLS Time (ET) NLS Price. NLS Share Volume. 16:00:03. $ 2.27. 740.

The average one-year price target for Biosig Technologies (NASDAQ:BSGM) has been revised to 5.74 / share. This is an increase of 38.89% from the prior estimate of 4.13 dated October 31, 2023.Find the latest SEC Filings data for BioSig Technologies, Inc. Common Stock (BSGM) at Nasdaq.com. BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal ...Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to delivering unprecedented ...Nasdaq: BSGM. November 2023. Page 2. BioSig Forward-Looking Statements. This presentation contains forward-looking statements including statements that address ...Nov 27, 2023 · The average one-year price target for Biosig Technologies (NASDAQ:BSGM) has been revised to 5.74 / share.This is an increase of 38.89% from the prior estimate of 4.13 dated October 31, 2023. The ...

Find the latest SEC Filings data for BioSig Technologies, Inc. Common Stock (BSGM) at Nasdaq.com.

13 nov 2023 ... 2023-11-13 | NDAQ:BSGM) BioSig Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules.

BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal ...BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to ...Westport, CT, March 24, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering ...Dec 4, 2023 · BSGM Earnings Date and Information. BioSig Technologies has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 13th, 2024 based off prior year's report dates. BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal ...Westport, CT, Nov. 12, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) ("BioSig" or the "Company"), a medical technology company commercializing a proprietary biomedical signal ...1 nov 2023 ... Silence Therapeutics (NASDAQ:SLN) avanzaron un 28,35% para establecerse en los 8,60 dólares. BioSig Technologies (NASDAQ:BSGM) subieron un 26,29 ...BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve ...Westport, CT, Feb. 21, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical ...

Nov 1, 2023 · Health Care Sector Update for 11/01/2023: ALDX, SLN, TNON, BSGM. Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index up 0.3% and the Health Care Select Sector SPDR ... Jul 20, 2023 · Shutthiphong Chandaeng. BioSig Technologies ( NASDAQ: BSGM) traded higher on Thursday after the medical device company announced that its subsidiary, BioSig AI Sciences, Inc., was selected to join ... Contact Data Andrew Ballou BioSig Technologies, Inc. Vice President, Investor Relations 55 Greens Farms Road, 1st Floor Westport, CT 06880 [email protected] 203-409-5444, x133Westport, CT, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Westport, CT, Nov. 9, 2023 -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company committed to ...Instagram:https://instagram. demo account mt4unlock hea reviewsbest dispensary pos systemcrowdfunding for real estate projects Find the latest Insider Activity data for BioSig Technologies, Inc. Common Stock (BSGM) at Nasdaq.com.BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), an advanced digital signal processing technology company delivering accuracy and precision to intracardiac signal visualization with its proprietary PURE EP™ System, today announced the retirement of chief financial officer Steve Chaussy following a distinguished career … what makes a quarter raredentalplans review Westport, CT, Nov. 13, 2023 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company …In the past year, BSGM shares have decreased 48.4% against the industry’s rise of 0.5%. Zacks Rank and Key Picks BioSig currently carries a Zacks Rank #3 (Hold). software options BSGM. Market, Nasdaq. List, NASDAQ-CM. Domestic Industry, None. Euroland-Industry, Medical technology & supplies. Shares (mil) 1, 88,11. Market Cap (mil), 22,93.BioSig Technologies, Inc.’s (Nasdaq: BSGM) subsidiary, ViralClear Pharmaceuticals, Inc., is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19.BioSig Technologies, Inc.’s (Nasdaq: BSGM) subsidiary, ViralClear Pharmaceuticals, Inc., is seeking to develop a novel pharmaceutical called merimepodib to treat patients with COVID-19.